0000000001109741

AUTHOR

G. Lavenia

showing 1 related works from this author

Role of trastuzumab in infracentimetric HER2-positive breast cancer: The southern Italy experience.

2014

e11512 Background: HER2 positive (HER2+) disease is relatively uncommon in early infracentimetric breast cancer (BC) accounting for approximately 10% of cases. Trastuzumab (T) based-adjuvant therap...

OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industryDiseasemedicine.diseaseBreast cancerOncologyTrastuzumabInternal medicineHER2 Positive Breast Cancermedicineskin and connective tissue diseasesbusinessneoplasmsmedicine.drugJournal of Clinical Oncology
researchProduct